Log in to search using one of your social media accounts:

 

Deep learning can quantify CAC on low-dose CT

CHICAGO - A deep-learning algorithm can automatically calculate coronary artery...Read more on AuntMinnie.comRelated Reading: CT CAC scoring tops age for predicting heart disease risk JACC: CT CAC scoring helps screen for CAD Coronary calcium predicts events, death, in younger adults JACC: Sedentary lifestyle puts calcium in coronaries Automated CAC fares well in CT lung screening scans
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

JoAnn Wooding is staring intently at the clear liquid dripping from a dark brown IV bag into her husband Peter’s arm. “Please be the drug, please be the drug,” she says. Married for more than 50 years, the Woodings are among the more than 5 million Americans who are facing Alzheimer’s disease, one of the most devastating diagnoses today. But instead of accepting the slow descent into memory loss, confusion and dementia, Peter–who has the disease–could be among the first to successfully stop that decline from happening. Peter, 77, is one of the 2,700 people around the world who are expect...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Alzheimer's Disease healthytime Longevity Source Type: news
We explored the clinical value of low-tube voltage prospective second-generation ECG-triggered 320-row CT angiography in infants with complex CHD (37 male, 23 female, aged 0 –2 years). The diagnostic accuracy of 320-row CT in complex CHD was 99.4% for intracardiac cardiovascular malformations, 99.8% for extracardiac cardiovascular malformations, and 100% for other malformations. The average subjective overall image quality score for cardiac structures was 3.7 ±  0.5 points. Second-generation 320-row CT angiography with low-tube voltage and prospective ECG-triggered volume target scanning allows accurate ...
Source: Clinical Imaging - Category: Radiology Authors: Source Type: research
HeartFlow said today it closed a $240 million Series E round of financing, with funds slated to support commercial expansion and studies of its HeartFlow FFRct analysis system. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary lesions. Financing in the round included investments from Wellington Management, Baillie Gifford &Company and existing investors, the company said. “We are delighted to be investing in HeartFlow on beha...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Funding Roundup HeartFlow Source Type: news
Source: Circulation: Cardiovascular Imaging - Category: Radiology Authors: Tags: Chronic Ischemic Heart Disease, Myocardial Infarction, Computerized Tomography (CT) Cardiovascular Images Source Type: research
It has never been easier to measure ECG and monitor heart health at home. New pocket-sized gadgets, chest straps, even specialized earbuds promise accurate measurements during sports activity, cooking or watching TV at home. AliveCor’s Kardia, MocaCare, Skeeper, just to name a few digital devices The Medical Futurist already reviewed. Recently, a Swedish company sent me their version and I eagerly tested it. Let’s see what the Coala Heart Monitor can offer. The ECG Revolution A real revolution started in cardiology: miniaturized and patient-friendly designs of ECG monitors, single- and multi-channel ECGs arrive...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Health Sensors & Trackers digital health ecg future Healthcare Innovation Personalized medicine review technology Source Type: blogs
ConclusionsMRI represents a promising imaging modality as an initial, single-shot study, for patients with suspected PH with the advantages of being non-invasive and having no radiation exposure.
Source: Lung - Category: Respiratory Medicine Source Type: research
In conclusion, most experimental data on immune changes with aging show a decline in many immune parameters when compared to young healthy subjects. The bulk of these changes is termed immunosenescence. Immunosenescence has been considered for some time as detrimental because it often leads to subclinical accumulation of pro-inflammatory factors and inflammaging. Together, immunosenescence and inflammaging are suggested to stand at the origin of most of the diseases of the elderly, such as infections, cancer, autoimmune disorders, and chronic inflammatory diseases. However, an increasing number of gerontologists have chall...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
This study aims to identify early factors that can be used as predictors for the presence of CBD stones, and by that to find which patient should undergo ERCP without an early EUS. METHODS: This is a retrospective cohort study including all patients who underwent EUS for suspected choledocholithiasis at the Soroka University Medical Center (SUMC) in the years 2009-2014. Data collection was performed by manual surveillance of patients' computerized files and data gathering after approval by the Soroka Institutional Review Board Results: One hundred seventy-five (175) patients were included in the study. The average age ...
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
We report a fatal case of nontraumatic hemopericardium caused by a ruptured dissecting pulmonary artery aneurysm in a 16-year-old girl with patent ductus arteriosus. The unenhanced postmortem computed tomography performed before autopsy was able to identify a large hemopericardium with a pulmonary artery aneurysm and lifting of mural calcification suggestive of a dissecting aneurysm. This enabled the pathologist to locate the exact rupture site that caused the hemopericardium.
Source: The American Journal of Forensic Medicine and Pathology - Category: Forensic Medicine Tags: Case Reports Source Type: research
Purpose of review Calcific aortic valve stenosis is the most prevalent valvular heart disease in the high-income countries. To this date, no medical therapy has been proven to prevent or to stop the progression of aortic valve stenosis. The physiopathology of aortic valve stenosis is highly complex and involves several signalling pathways, as well as genetic related factors, which delay the elaboration of effective pharmacotherapies. Moreover, it is difficult to predict accurately the progression of the valve stenosis and finding the optimal timing for aortic valve replacement remains challenging. Therefore, the present ...
Source: Current Opinion in Cardiology - Category: Cardiology Tags: VALVULAR HEART DISEASE: Edited by Bobby Yanagawa and Subodh Verma Source Type: research
More News: Calcium | Cardiology | Heart | Heart Disease | Learning | PET Scan | Universities & Medical Training